James G. Marken
Overview
James G. Marken received an average of $1M in total compensation, including $335K in salary, at ANI Pharmaceuticals from 2013 to 2021.
2021ANI PharmaceuticalsSenior Vice President, Operations and Product Development
2020ANI PharmaceuticalsSenior Vice President, Operations and Product Development
2019ANI PharmaceuticalsSenior Vice President, Operations and Product Development
2018ANI PharmaceuticalsSenior Vice President, Operations and Product Development
2017ANI PharmaceuticalsSenior Vice President, Operations and Product Development
2016ANI PharmaceuticalsSenior Vice President, Operations and Product Development
2015ANI PharmaceuticalsSenior Vice President, Operations and Product Development
2014ANI PharmaceuticalsSenior Vice President, Operations and Product Development
2013ANI PharmaceuticalsVice President, Operations
Source: SEC filings on March 25, 2022, April 29, 2021, April 23, 2020, April 4, 2019, April 6, 2018, April 6, 2017, and April 14, 2016.
Related executives
We found 11 more executives who work or worked at ANI Pharmaceuticals.
Nikhil Lalwani
ANI Pharmaceuticals
Chief Executive Officer
Stephen Carey
ANI Pharmaceuticals
Chief Financial Officer
Christopher Mutz
ANI Pharmaceuticals
Head of Rare Disease
Ori Gutwerg
ANI Pharmaceuticals
Senior Vice President, Generics
Robert Schrepfer
ANI Pharmaceuticals
Former Senior Vice President, New Business Development and Specialty Sales
Patrick Walsh
ANI Pharmaceuticals
Chief Executive Officer
Arthur Przybyl
ANI Pharmaceuticals
Chief Executive Officer
Charlotte Arnold
ANI Pharmaceuticals
Chief Financial Officer
News
ANI Pharmaceuticals CEO Nikhil Lalwani's 2021 pay jumps 76% to $6.5M
March 25, 2022
ANI Pharmaceuticals CEO Nikhil Lalwani receives $3.7M in 2020
April 29, 2021
ANI Pharmaceuticals CEO Arthur Przybyl's 2019 pay jumps 39% to $5.8M
April 23, 2020
ANI Pharmaceuticals CEO Arthur Przybyl's 2018 pay rises 17% to $4.2M
April 4, 2019